SCHEMBL9402365

SCHEMBL9402365

CCCCc1nnc(Sc2ccccc2)n1Cc1ccc(N)cc1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402219 0.85 — —
SCHEMBL9402406 0.83 ALDH1A1 (0.49) —
SCHEMBL9402239 0.79 ALDH1A1 (0.46) —
SCHEMBL9402282 0.78 AGTR1 (0.49) —
SCHEMBL9402394 0.78 — —
SCHEMBL9402287 0.78 LMNA (0.51) —
SCHEMBL9402246 0.74 ALDH1A1 (0.51) —
SCHEMBL9402392 0.74 ALDH1A1 (0.52) —
SCHEMBL9402256 0.73 KDM4E (0.45) TLR7
SCHEMBL9402206 0.73 AGTR1 (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
EP-0409332-A2 Substituted triazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1991-01-23 — — EP disclosed
Send feedback